Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myeloma.
about
Current Trends of Renal Impairment in Multiple MyelomaThe next generation of novel therapies for the management of relapsed multiple myeloma.Successful treatment of patients with newly diagnosed/untreated light chain multiple myeloma with a combination of bendamustine, prednisone and bortezomib (BPV).Successful treatment of myeloma cast nephropathy using bortezomib-based chemotherapy plus selective plasma exchange.Therapeutic Efficacy and Cost Effectiveness of High Cut-Off Dialyzers Compared to Conventional Dialysis in Patients with Cast Nephropathy.Myeloma today: Disease definitions and treatment advances.A pharmacokinetics and safety phase 1/1b study of oral ixazomib in patients with multiple myeloma and severe renal impairment or end-stage renal disease requiring haemodialysisContinuous treatment with lenalidomide and low-dose dexamethasone in transplant-ineligible patients with newly diagnosed multiple myeloma in Asia: subanalysis of the FIRST trial.Limiting early mortality: Do's and don'ts in the management of patients with newly diagnosed multiple myeloma.Iodine-based contrast media, multiple myeloma and monoclonal gammopathies: literature review and ESUR Contrast Media Safety Committee guidelines.Pomalidomide plus low-dose dexamethasone in patients with relapsed/refractory multiple myeloma and moderate renal impairment: a pooled analysis of three clinical trials.Managing renal complications in multiple myeloma.Current treatments for renal failure due to multiple myeloma.Patients with multiple myeloma have excellent long-term outcomes after recovery from dialysis-dependent acute kidney injury.Daratumumab, Elotuzumab, and the Development of Therapeutic Monoclonal Antibodies in Multiple Myeloma.Healthcare resource use and costs associated with renal impairment in US patients with bone metastases from solid tumors.Restoration of renal function in patients with newly diagnosed multiple myeloma is not associated with improved survival: a population-based study.Renal impairment and use of nephrotoxic agents in patients with multiple myeloma in the clinical practice setting in the United States.Renal disease related to Waldenström macroglobulinaemia: incidence, pathology and clinical outcomes.Multiple Myeloma: Diagnosis and Treatment.Renal Dysfunction and Recovery following Initial Treatment of Newly Diagnosed Multiple Myeloma
P2860
Q26740444-A70089DE-F535-46F2-9FA1-4BC68CEE5D7DQ30248534-DE2B22F2-AA7C-42C2-A2A2-0C489EBE8655Q33442039-01A9DB76-222F-42BA-88E8-68661805CBBCQ33622292-48EDCC20-26A8-4215-A12C-9CF5FB4D56AFQ36088601-87D2C288-C125-4A35-850E-91C5A5A18194Q36470699-34F116C2-907B-4D7F-9D5B-786D336243B8Q37375516-36355E50-F8CD-4DEC-A765-8165C21D9155Q37664019-60B46AD1-A586-456D-B44E-F271958B8283Q38555091-21658F86-18AE-4D44-8308-2FEC199261FDQ38601097-C86ED572-97E6-4068-B27F-6753B7863AE7Q38856521-344EEB85-E802-4A77-83C6-337D8A9923E5Q38900024-8060E85D-F0EA-4D46-B5DA-62177294F47FQ38959138-CDC0CCE8-71AB-4448-988C-216901550C71Q38976968-F4C1C437-8856-40F6-9386-AF5487A8CB5EQ38996881-2E17AD7D-D77F-4C19-97BC-C001BBF62984Q40006468-F9FC06DB-7549-4A87-9BE6-9EF3CBFE9BF8Q40299548-4609EA41-BA16-44C4-BC1E-BA3CCC04E37AQ40975758-66CFC2DF-FCB8-44DA-8134-490167652CF1Q48137831-26602A59-54AB-47F1-9A72-C32DC696930EQ55119496-C9ECAF66-DF42-4DB1-8055-4C3945E738D2Q58762704-F6458A2F-8315-48C8-B318-70B96C942F4B
P2860
Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myeloma.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Improvement in renal function ...... ly diagnosed multiple myeloma.
@ast
Improvement in renal function ...... ly diagnosed multiple myeloma.
@en
type
label
Improvement in renal function ...... ly diagnosed multiple myeloma.
@ast
Improvement in renal function ...... ly diagnosed multiple myeloma.
@en
prefLabel
Improvement in renal function ...... ly diagnosed multiple myeloma.
@ast
Improvement in renal function ...... ly diagnosed multiple myeloma.
@en
P2093
P2860
P356
P1433
P1476
Improvement in renal function ...... ly diagnosed multiple myeloma.
@en
P2093
A Dispenzieri
S J Russell
P2860
P2888
P356
10.1038/BCJ.2015.20
P577
2015-03-20T00:00:00Z